Sai Life

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE570L01029
  • NSEID: SAILIFE
  • BSEID: 544306
INR
849.00
37.8 (4.66%)
BSENSE

Feb 06

BSE+NSE Vol: 46.31 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Acutaas Chemical
Sai Life
Natco Pharma
Astrazeneca Phar
Neuland Labs.
ERIS Lifescience
Pfizer
Caplin Point Lab
Alembic Pharma
Jubilant Pharmo
Piramal Pharma

Why is Sai Life Sciences Ltd ?

1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.20 times
2
Healthy long term growth as Operating profit has grown by an annual rate 87.31%
3
With a growth in Operating Profit of 21.76%, the company declared Very Positive results in Dec 25
  • The company has declared positive results for the last 4 consecutive quarters
  • NET SALES(Latest six months) At Rs 1,093.93 cr has Grown at 30.96%
  • OPERATING PROFIT TO INTEREST(Q) Highest at 19.37 times
  • PBDIT(Q) Highest at Rs 187.85 cr.
4
With ROE of 12.6, it has a Very Expensive valuation with a 7.9 Price to Book Value
  • Over the past year, while the stock has generated a return of 14.63%, its profits have risen by 82%
5
High Institutional Holdings at 52.81%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Sai Life should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Sai Life for you?

High Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Sai Life
14.63%
0.38
38.76%
Sensex
7.07%
0.61
11.53%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
19.10%
EBIT Growth (5y)
87.31%
EBIT to Interest (avg)
6.75
Debt to EBITDA (avg)
1.56
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.68
Tax Ratio
25.31%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
52.81%
ROCE (avg)
11.61%
ROE (avg)
12.62%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
53
Industry P/E
32
Price to Book Value
7.90
EV to EBIT
39.82
EV to EBITDA
29.48
EV to Capital Employed
7.58
EV to Sales
8.32
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
16.59%
ROE (Latest)
12.62%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Mildly Bullish
KST
Dow Theory
No Trend
OBV
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

25What is working for the Company
NET SALES(Latest six months)

At Rs 1,093.93 cr has Grown at 30.96%

OPERATING PROFIT TO INTEREST(Q)

Highest at 19.37 times

PBDIT(Q)

Highest at Rs 187.85 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 33.76%

PBT LESS OI(Q)

Highest at Rs 134.08 cr.

PAT(Q)

Highest at Rs 106.58 cr.

EPS(Q)

Highest at Rs 4.75

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Sai Life

Operating Profit to Interest - Quarterly
Highest at 19.37 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 134.08 cr has Grown at 58.1% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 84.83 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 106.58 cr has Grown at 48.8% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 71.61 Cr
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Latest six months
At Rs 1,093.93 cr has Grown at 30.96%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 187.85 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 33.76%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 134.08 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 106.58 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 4.75
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)